Results from IRL790C005-A Randomized, Double-Blind, Placebo-Controlled Phase IIb Study Evaluating the Efficacy of Mesdopetam on Daily On-Time Without Troublesome Dyskinesia in Patients with Parkinson's Disease
MOVEMENT DISORDERS（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined